Brunasso, Alexandra M G <br/><br/>
Tolerability and safety of biological therapies for psoriasis in daily clinical practice: a study of 103 Italian patients.  [electronic resource] 

 -  Acta dermato-venereologica  Jan 2011 
 - 44-9 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1651-2057 
<br/><br/><label>Standard No.: </label>10.2340/00015555-0959  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adalimumab<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Anti-Inflammatory Agents--adverse effects<br/>Antibodies, Monoclonal--adverse effects<br/>Antibodies, Monoclonal, Humanized<br/>Dermatologic Agents--adverse effects<br/>Etanercept<br/>Female<br/>Humans<br/>Immunoglobulin G--adverse effects<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Psoriasis--drug therapy<br/>Receptors, Tumor Necrosis Factor--therapeutic use<br/>Young Adult